David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$1.52B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.43B |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$798M |
| 4 |
Amazon
AMZN
|
+$646M |
| 5 |
Texas Instruments
TXN
|
+$619M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$1.31B |
| 2 |
Broadcom
AVGO
|
+$1.01B |
| 3 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$863M |
| 4 |
Western Digital
WDC
|
+$595M |
| 5 |
Meta Platforms (Facebook)
META
|
+$591M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 35.73% |
| 2 | Technology | 18.6% |
| 3 | Consumer Discretionary | 9.12% |
| 4 | Healthcare | 7.62% |
| 5 | Industrials | 7.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2826
CALL
Hecla Mining
HL
$14.3B
| $2.3M | ﹤0.01% |
+120,100
| New | +$1.83M |
|
|
TRUE
2827
DELISTED
TrueCar
TRUE
| $2.3M | ﹤0.01% |
1,018,566
-18,695
| -2% | -$40.1K |
|
|
DCH
2828
Dauch Corp
DCH
$1.52B
| $2.3M | ﹤0.01% |
358,999
-423,375
| -54% | -$2.63M |
|
|
BCAX
2829
Bicara Therapeutics
BCAX
$1.64B
| $2.3M | ﹤0.01% |
+136,522
| New | +$2.33M |
|
|
CWAN
2830
DELISTED
Clearwater Analytics
CWAN
| $2.29M | ﹤0.01% |
+95,117
| New | +$1.91M |
|
2831
Benchmark Electronics
BHE
$2.64B
| $2.29M | ﹤0.01% |
53,585
-30,880
| -37% | -$1.34M |
|
2832
PUT
Array Technologies
ARRY
$725M
| $2.28M | ﹤0.01% |
247,800
| – | – |
|
2833
PUT
Warrior Met Coal
HCC
$5.7B
| $2.28M | ﹤0.01% |
25,900
+6,200
| +31% | +$466K |
|
2834
Beazer Homes USA
BZH
$885M
| $2.28M | ﹤0.01% |
112,508
+103,784
| +1,190% | +$2.31M |
|
2835
PUT
Align Technology
ALGN
$11.4B
| $2.28M | ﹤0.01% |
14,600
| – | – |
|
2836
Editas Medicine
EDIT
$502M
| $2.27M | ﹤0.01% |
1,109,590
+993,411
| +855% | +$2.87M |
|
2837
CALL
Campbell Soup
CPB
$6.95B
| $2.27M | ﹤0.01% |
81,500
-108,000
| -57% | -$3.25M |
|
2838
CALL
Papa John's
PZZA
$765M
| $2.27M | ﹤0.01% |
59,000
-2,600
| -4% | -$115K |
|
2839
PUT
Grab
GRAB
$14.9B
| $2.27M | ﹤0.01% |
455,000
+180,000
| +65% | +$995K |
|
2840
Stride
LRN
$3.54B
| $2.27M | ﹤0.01% |
34,949
-91,948
| -72% | -$8.35M |
|
|
ALMS
2841
Alumis Inc
ALMS
$3.09B
| $2.26M | ﹤0.01% |
+231,747
| New | +$1.62M |
|
2842
PUT
Standex International
SXI
$3.67B
| $2.26M | ﹤0.01% |
10,400
+3,200
| +44% | +$742K |
|
2843
Ingersoll Rand
IR
$31B
| $2.26M | ﹤0.01% |
28,519
+23,966
| +526% | +$1.89M |
|
2844
CALL
Zimmer Biomet
ZBH
$19.3B
| $2.26M | ﹤0.01% |
+25,100
| New | +$2.38M |
|
2845
CS Disco
LAW
$281M
| $2.26M | ﹤0.01% |
290,658
+52,924
| +22% | +$373K |
|
2846
CALL
Freshpet
FRPT
$3.5B
| $2.25M | ﹤0.01% |
37,000
-64,400
| -64% | -$3.65M |
|
2847
Puma Biotechnology
PBYI
$473M
| $2.25M | ﹤0.01% |
378,296
-120,302
| -24% | -$639K |
|
2848
PUT
Shell
SHEL
$249B
| $2.25M | ﹤0.01% |
30,600
+5,400
| +21% | +$398K |
|
2849
CALL
Vermilion Energy
VET
$1.91B
| $2.25M | ﹤0.01% |
270,000
| – | – |
|
2850
Zentalis Pharmaceuticals
ZNTL
$367M
| $2.24M | ﹤0.01% |
1,660,378
+251,575
| +18% | +$366K |
|
Similar funds
David Shaw's Q4 2025 Portfolio in Review
As of Q4 2025, David Shaw held 5,141 positions worth $182B, up 3% from $177B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
David Shaw's Q4 2025 filing shows 639 new, 1,734 increased, 1,574 reduced and 583 closed positions. Its largest new stake was iShares Core S&P 500 ETF: 1,175,000 shares worth $805M. The largest sale was Micron Technology, an estimated $1.31B.
By sector, the portfolio is most concentrated in Miscellaneous at 36% of assets, down from 39% a quarter earlier, followed by Technology and Consumer Discretionary.
- David Shaw's largest Q4 2025 buy was iShares Core S&P 500 ETF: 1,175,000 shares worth $805M.
- David Shaw added most to Advanced Micro Devices in Q4 2025, an estimated $1.52B increase.
- David Shaw's biggest Q4 2025 reduction was Micron Technology, cutting an estimated $1.31B.
- David Shaw fully exited Vanguard Short-Term Corporate Bond ETF in Q4 2025, selling an estimated $499M.
- David Shaw's ten largest holdings make up 12% of its $182B portfolio in Q4 2025.
- David Shaw opened 639 new positions and closed 583 in Q4 2025.
- David Shaw's portfolio value rose 3% quarter-over-quarter to $182B.
Based on D.E. Shaw & Co's 13F filing for Q4 2025, filed 17 Feb 2026.